G&L Healthcare Advisors

What G&L Healthcare Advisors does

G&L Healthcare Advisors, operating under the DBA G&L Scientific, is a privately held pharmaceutical services firm. Firmographic data places its origin in 2016 with a registered presence in Warren, United States, while the company's operational headquarters and primary contact infrastructure (phone +44 020 3143 2210) are in London, United Kingdom, and the live website is gandlscientific.com. The firm is led by co-founders Stephen Loughrey (Founder & CEO) and Peter Griffin (Founder), and operates with 251–500 employees globally. Note: the firmographic short description characterizes the firm as a healthcare consultancy offering benchmarking, market expansion, and operational optimization, whereas the rest of the data describes a pharmaceutical regulatory and quality services platform — this discrepancy is reflected as-is from the source data.

G&L positions itself as an Integrated Product Development and Market Access Platform, providing services across the full pharmaceutical product lifecycle: pharmaceutical development (drug substance, drug product, manufacturing operations, GMP compliance), program strategy and pre-clinical (development strategy, program evaluation, GLP compliance), clinical development (strategy, operations, medical writing, GCP compliance, pre-approval, authoring/publishing, post-approval), regulatory affairs (CMC, ATMPs, HTA & Evidence Strategy), market access (strategy, achieving access, artwork & labeling, distribution, product release), commercialization, quality & compliance (pre-approval inspections, vendor audits, inspection readiness), and advisory services (organizational assessment, implementation/excellence, M&A regulatory due diligence, digital technology advisory). The company claims coverage of 100+ global markets and reports a 7–14 day speed-to-scale benchmark versus 4–8 weeks for traditional CROs.

The core technology asset is The Source, a global consultant platform launched 2025-12-03 that enables consultants to register, build profiles, receive personalized opportunity alerts, submit proposals, and track engagement with G&L project teams. The business model is professional services revenue across three streams: Regulatory Affairs Services, Quality Assurance Services, and Functional Outsourcing/Staff Augmentation delivered via a Flexible Functional Service Provider (FSP) model. The company has been recognized with the Queen's Award for Enterprise 2022, the King's Award for Enterprise 2024, and ISO certification, and markets through a Knowledge Hub, direct consultation booking, and case studies. Pricing is not publicly disclosed; services are sold through consultative, tailored engagements.

Name

G&L Healthcare Advisors

Legal name

G&L Scientific

Website

https://gandlhealth.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Short description

G&L Healthcare Advisors (also known as G&L Scientific) is a private pharmaceutical consultancy delivering regulatory affairs, quality compliance, and market access services across 100+ global markets via a Functional Service Provider model and The Source consultant platform.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory and Quality Consulting

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE)

akta.pro secondary industries

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Medical Writing & Clinical Documentation FSP (HLAGAOAC), CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK)

Keywords

• Pharmaceutical consulting
• Regulatory affairs services
• Quality assurance compliance
• Clinical development services
• Market access strategy

Headquarters

HQ city

Warren

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Regulatory Affairs Services: Comprehensive regulatory services across the entire product lifecycle covering CMC, ATMPs, clinical and market access across global markets.
2. Quality Assurance Services: Quality and compliance services including GMP, GCP, GLP compliance and inspection readiness.
3. Functional Outsourcing / Staff Augmentation: Flexible FSP and managed teams providing scalable specialist resources to pharmaceutical and life sciences organizations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

G&L Healthcare Advisors (doing business as G&L Scientific) is an Integrated Product Development and Market Access Platform serving pharmaceutical, biopharmaceutical, and biotechnology organizations. The company delivers comprehensive professional services across the entire product lifecycle — from drug substance and drug product development, through clinical trials, regulatory affairs (CMC, ATMPs, clinical, market access), quality compliance (GMP, GCP, GLP), and post-approval support — via Full Service Outsourcing, Functional Service Provider (FSP), and Staff Augmentation operating models.

Product overview

G&L Scientific is an Integrated Product Development and Market Access Platform providing a single, unified source of best-in-class solutions across the entire pharmaceutical product pipeline. The platform encompasses comprehensive services organized into eight major categories: Pharmaceutical Development (Drug Substance Development, Drug Product Development, Manufacturing Operations, Manufacturing Compliance), Program Strategy & Pre-Clinical (Development Strategy, Program Evaluation, Non-Clinical Study Execution, Non-Clinical Regulatory Submissions, Non-Clinical Compliance), Clinical Development (Clinical Development Strategy, Clinical Operations & Study Management, Medical Writing & Regulatory Submissions, Clinical Compliance, Pre-Approval, Authoring Publishing & Submissions, Post-Approval), Regulatory, Market Access (Strategy Development, Achieving Market Access, Artwork & Labeling, Distribution, Product Release Process), Commercialization, Quality & Compliance (Pre-Approval Inspections & Vendor Audits, GLP, GCP, GMP, Inspection Readiness), and Advisory, Transformation & Design (Organizational Assessment Strategy & Design, Implementation Excellence & Transformation, M&A Regulatory Due Diligence & Integration, Digital Technology Advisory). The platform also includes The Source, a global consultant platform, and offers flexible delivery models including Full Service Outsourcing, Functional Service Provider (FSP), and Staff Augmentation. G&L's expertise spans CMC, ATMPs, HTA & Evidence Strategy, Market Access across 100+ global markets.

Differentiator

Problem solved

Functional benefit

Brands

• The Source: G&L Scientific's global consultant platform enabling registered consultants to create profiles, receive personalized opportunity alerts, express interest in proposals, and track progress with G&L project teams.

Products and services

• Pharmaceutical Development End-to-end drug substance (API) and drug product development, manufacturing operations, and manufacturing compliance (GMP) services supporting pharmaceutical product development across the product lifecycle, for pharma and biotech clients.
• Program Strategy & Pre-Clinical Development strategy, program evaluation, non-clinical study execution, non-clinical regulatory submissions, and GLP compliance services for assessing and optimizing preclinical pharmaceutical development programs.
• Clinical Development Clinical development strategy, clinical operations and study management, medical writing and regulatory submissions, GCP compliance, pre-approval services, authoring/publishing/submissions, and post-approval services for managing clinical trials and driving asset valuation.
• Regulatory Affairs Comprehensive regulatory services across the entire product lifecycle covering CMC, ATMPs, clinical and market access submissions, agency interactions, and pre-approval / post-approval regulatory support across 100+ global markets.
• Market Access Strategy development, achieving market access, HTA and evidence strategy, artwork and labeling, distribution, and product release process services aimed at achieving product reimbursement and best-in-class market positioning.
• Quality & Compliance Pre-approval inspections, vendor audits, GLP / GCP / GMP compliance, and inspection readiness services ensuring regulatory compliance preparation and ongoing quality adherence for pharmaceutical organizations.
• Advisory, Transformation & Design Organizational assessment, strategy and design, implementation/excellence/transformation, M&A regulatory due diligence and integration, and digital technology advisory services for pharmaceutical organizations.
• Functional Outsourcing Flexible FSP and managed teams providing scalable specialist regulatory, quality, clinical, and market access resources to pharmaceutical and life sciences organizations, with 7-14 day speed to scale.
• The Source (Global Consultant Platform) Global consultant platform enabling consultant registration, profile creation, personalized opportunity alerts, proposal submission, progress tracking, and direct communication with G&L project teams.

Quantifiable outcome

• 7-14 days speed to scale (vs 4-8 weeks average for traditional CROs)

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ICON plc: Top-3 global CRO offering full-service, FSP, and laboratory services — broad incumbent competitor for large enterprise pharma mandates including regulatory and clinical work.
• Parexel International: Large global CRO with strong regulatory affairs and FSP capabilities — competes for the same enterprise pharma panel positions G&L targets.
• IQVIA: World's largest CRO with comprehensive FSP, full-service, and technology offerings — sets the pricing and bid-list dynamics against which specialist FSPs like G&L must compete.
• Charles River Laboratories: Major preclinical and manufacturing services provider overlapping with G&L's CMC, drug substance, and manufacturing compliance offerings — broader incumbent with adjacent scope.

Direct peers

• PharmaLex (Cencora): Specialist regulatory affairs, quality, and pharmacovigilance consulting firm — comparable in regulatory services focus, now operating under Cencora but historically a peer FSP/consulting competitor.
• Premier Research: Privately held CRO/FSP provider with strong regulatory and clinical development capabilities serving small-to-mid biotech and specialty pharma — directly comparable in target customer and FSP delivery model.
• Worldwide Clinical Trials: Mid-sized, privately held global CRO with deep FSP and full-service offerings across regulatory, clinical, and post-approval services — the closest structural analogue to G&L in scale and mid-market positioning.
• Advanced Clinical: Privately held clinical research services firm with FSP/functional outsourcing offerings — comparable in size, FSP focus, and customer segment (mid-market biotech).
• BioPoint Inc. FSP-focused life sciences services firm providing regulatory, clinical, and quality staffing solutions — directly competes in the same functional outsourcing niche as G&L.

Emerging players

• Veeva Systems: Provider of regulatory information management and clinical technology platforms serving pharma R&D — overlaps with G&L's regulatory services and adjacent to The Source platform strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/g-l-health

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about G&L Healthcare Advisors